Hugel Reports Q1-Q3 Net Sales of KRW352.1 Billion, up 15% Year-on-Year
- Hugel reported consolidated net sales of KRW352.1 billion for the first three quarters of 2026, a 15% year-on-year increase.
- In the third quarter, Hugel recorded KRW97.5 billion in net sales, KRW18.1 billion in operating profit, and KRW4.7 billion in net profit.
- Third-Quarter botulinum toxin sales fell 21% year-on-year to KRW47.2 billion, while HA filler and skinbooster sales rose 2% to KRW30.9 billion.
- Hugel said sales rose 54% in Korea and 18% in Europe and other regions, while its shift to a CSO model in the U.S. had short-term effects on results.
15 Articles
15 Articles
Medical aesthetics company Hugel reported a 61.8% decrease in operating profit in the third quarter of this year compared to the same period last year. Although sales of botulinum toxin and fillers increased in the domestic market and growth continued in overseas markets such as Europe, China, and Brazil, profitability deteriorated due to factors including the restructuring of its U.S. business. Hugel has taken steps to enhance shareholder value…
The Paintsville Herald
Hugel reports Q1-Q3 net sales of KRW352.1 billion, up 15% year-on-year
Q3 net sales reach KRW97.5 billion amid U.S. sales model changes, as the company builds a foundation for mid- to long-term growthQ3 combined net sales of botulinum toxin, HA fillers, and skinboosters surge 54% in Korea and 18% in Europe…
占쏙옙占쏙옙占 占쏙옙占쏙옙 3占싻깍옙 占쏙옙占쏙옙 占쏙옙占쏙옙占쏙옙占 占쏙옙占 占쏙옙占쏙옙 占쏙옙占쏙옙 占쏙옙占 占쏙옙占쏙옙占생댓옙.占쏙옙占쏙옙占쏙옙 占쏙옙占쏙옙 占쏙옙 占쌍울옙 占쏙옙恙∽옙占 占쏙옙占썲세占쏙옙 占싱어갔다占쏙옙占쏙옙 占쌍뤄옙 占쏙옙품占쏙옙 占쏙옙占쏙옙占쏙옙占 占쏙옙占 占쏙옙占쏙옙占 占쌕면서 占쏙옙체 占쏙옙占쏙옙占 占쏙옙占쏙옙 占쏙옙占싣댄옙. 占싱깍옙 占쏙옙占쏙옙 占쏙옙占쏙옙 占쏙옙...
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
